Discovery of Novel DUSP4 Inhibitors through the Virtual Screening with Docking Simulations 


Vol. 35,  No. 9, pp. 2655-2659, Sep.  2014
10.5012/bkcs.2014.35.9.2655


PDF
  Tumbnail

  Abstract

Dual specificity protein phosphatase 4 (DUSP4) has been considered a promising target for the development of therapeutics for various human cancers. Here, we report the first example for a successful application of the structure-based virtual screening to identify the novel small-molecule DUSP4 inhibitors. As a consequence of the virtual screening with the modified scoring function to include an effective molecular solvation free energy term, five micromolar DUSP4 inhibitors are found with the associated IC50 values ranging from 3.5 to 10.8 μM. Because these newly identified inhibitors were also screened for having desirable physicochemical properties as a drug candidate, they may serve as a starting point of the structure-activity relationship study to optimize the medical efficacy. Structural features relevant to the stabilization of the new inhibitors in the active site of DUSP4 are discussed in detail.

  Statistics
Cumulative Counts from November, 2022
Multiple requests among the same browser session are counted as one view. If you mouse over a chart, the values of data points will be shown.


  Cite this article

[IEEE Style]

H. Park, T. J. Jeon, P. N. Chien, S. Y. Park, S. M. Oh, S. J. Kim, S. E. Ryu, "Discovery of Novel DUSP4 Inhibitors through the Virtual Screening with Docking Simulations," Bulletin of the Korean Chemical Society, vol. 35, no. 9, pp. 2655-2659, 2014. DOI: 10.5012/bkcs.2014.35.9.2655.

[ACM Style]

Hwangseo Park, Tae Jin Jeon, Pham Ngoc Chien, So Ya Park, Sung Min Oh, Seung Jun Kim, and Seong Eon Ryu. 2014. Discovery of Novel DUSP4 Inhibitors through the Virtual Screening with Docking Simulations. Bulletin of the Korean Chemical Society, 35, 9, (2014), 2655-2659. DOI: 10.5012/bkcs.2014.35.9.2655.